Rakesh N. Veedu - Search Results

Year	Number of Results
2005	1
2007	4
2008	2
2009	4
2010	2
2011	2
2012	11
2013	7
2014	2
2015	6
2016	3
2017	7
2018	8
2019	9
2020	9
2021	9
2022	4
2023	6
2024	2

1

Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics.

Yang D, Zhang W, Zhang H, Zhang F, Chen L, Ma L, Larcher LM, Chen S, Liu N, Zhao Q, Tran PHL, Chen C, Veedu RN, Wang T. Yang D, et al. Among authors: veedu rn. Theranostics. 2020 Feb 19;10(8):3684-3707. doi: 10.7150/thno.41580. eCollection 2020. Theranostics. 2020. PMID: 32206116 Free PMC article. Review.

2

Aptamer-engineered (nano)materials for theranostic applications.

Rabiee N, Chen S, Ahmadi S, Veedu RN. Rabiee N, et al. Among authors: veedu rn. Theranostics. 2023 Sep 25;13(15):5183-5206. doi: 10.7150/thno.85419. eCollection 2023. Theranostics. 2023. PMID: 37908725 Free PMC article. Review.

3

Recent Advances in Oligonucleotide Therapeutics in Oncology.

Xiong H, Veedu RN, Diermeier SD. Xiong H, et al. Among authors: veedu rn. Int J Mol Sci. 2021 Mar 24;22(7):3295. doi: 10.3390/ijms22073295. Int J Mol Sci. 2021. PMID: 33804856 Free PMC article. Review.

4

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease.

Chakravarthy M, Chen S, Dodd PR, Veedu RN. Chakravarthy M, et al. Among authors: veedu rn. Theranostics. 2017 Sep 5;7(16):3933-3947. doi: 10.7150/thno.21529. eCollection 2017. Theranostics. 2017. PMID: 29109789 Free PMC article. Review.

5

DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics.

Larcher LM, Pitout IL, Keegan NP, Veedu RN, Fletcher S. Larcher LM, et al. Among authors: veedu rn. Nucleic Acid Ther. 2023 Jun;33(3):178-192. doi: 10.1089/nat.2022.0066. Epub 2023 Apr 21. Nucleic Acid Ther. 2023. PMID: 37093127 Free PMC article. Review.

6

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs.

Macdonald J, Henri J, Roy K, Hays E, Bauer M, Veedu RN, Pouliot N, Shigdar S. Macdonald J, et al. Cancers (Basel). 2018 Jan 12;10(1):19. doi: 10.3390/cancers10010019. Cancers (Basel). 2018. PMID: 29329202 Free PMC article. Review.

7

Antisense Oligonucleotides as Potential Therapeutics for Type 2 Diabetes.

Chen S, Sbuh N, Veedu RN. Chen S, et al. Among authors: veedu rn. Nucleic Acid Ther. 2021 Feb;31(1):39-57. doi: 10.1089/nat.2020.0891. Epub 2020 Oct 7. Nucleic Acid Ther. 2021. PMID: 33026966 Review.

8

Nanoparticles-assisted aptamer biosensing for the detection of environmental pathogens.

Rahimizadeh K, Zahra QUA, Chen S, Le BT, Ullah I, Veedu RN. Rahimizadeh K, et al. Among authors: veedu rn. Environ Res. 2023 Dec 1;238(Pt 1):117123. doi: 10.1016/j.envres.2023.117123. Epub 2023 Sep 16. Environ Res. 2023. PMID: 37717803 Review.

9

Medicinal chemistry of aptamers.

Veedu RN. Veedu RN. Curr Top Med Chem. 2015;15(12):1065. doi: 10.2174/1568026615666150413161707. Curr Top Med Chem. 2015. PMID: 25866280

10

Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics.

Le BT, Raguraman P, Kosbar TR, Fletcher S, Wilton SD, Veedu RN. Le BT, et al. Among authors: veedu rn. Mol Ther Nucleic Acids. 2019 Mar 1;14:142-157. doi: 10.1016/j.omtn.2018.11.007. Epub 2018 Nov 20. Mol Ther Nucleic Acids. 2019. PMID: 30594893 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

90 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year